Point72 Hong Kong LTD Biocryst Pharmaceuticals Inc Transaction History

Point72 Hong Kong LTD

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $56,911 - $77,367	11,428 New	11,428 $68,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $198,838 - $272,918	18,428 New	18,428 $232,000
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $57,320 - $129,898	-7,265 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $83,983 - $143,556	7,265 New	7,265 $118,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $22,147 - $30,626	-1,981 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $28,150 - $34,964	1,981 New	1,981 $28,000
Q2 2021 Aug 16, 2021	SELL	$9.5 - $17.24 $43,871 - $79,614	-4,618 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.37 - $13.61 $2,579 - $4,763	350 Added 8.2%	4,618 $47,000
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $14,383 - $36,747	4,268 New	4,268 $32,000
Q3 2020 Nov 16, 2020	SELL	$3.43 - $5.53 $24,641 - $39,727	-7,184 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $8,409 - $24,829	4,426 Added 160.48%	7,184 $34,000
Q1 2020 May 15, 2020	BUY	$1.6 - $4.11 $326 - $838	204 Added 7.99%	2,758 $6,000
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $4,060 - $8,811	2,554 New	2,554 $9,000
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $7,295 - $22,939	-2,507 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.38 - $9.72 $17,025 - $22,424	2,307 Added 1153.5%	2,507 $20,000
Q4 2018 Feb 14, 2019	BUY	$6.51 - $9.6 $1,302 - $1,920	200 New	200 $2,000

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.